MedAdvisor Extends Share Purchase Plan Deadline

MedAdvisor Limited ( (AU:MDR) ) has shared an announcement.

MedAdvisor Limited has announced an extension of its Share Purchase Plan (SPP) deadline from April 17 to April 30, 2025, to provide eligible shareholders additional time to participate. This extension reflects the company’s commitment to engaging its stakeholders and potentially increasing shareholder participation, which may impact its financial strategy and market positioning.

More about MedAdvisor Limited

MedAdvisor Solutions (ASX: MDR) is a global leader in pharmacy-driven patient engagement solutions, offering personalized patient experiences to simplify the medication journey. Utilizing THRiV, a cloud-based, AI-enabled platform, the company enhances pharmacy workflow and patient engagement. MedAdvisor collaborates with over 34,000 pharmacies in the US, reaching more than two-thirds of the population, and is used by over 95% of Australian pharmacies, connecting with over 3.7 million patients.

YTD Price Performance: -58.64%

Average Trading Volume: 656,235

Technical Sentiment Signal: Buy

Current Market Cap: A$54.39M

For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.